Gorovits, Boris https://orcid.org/0000-0001-9405-7718
Azadeh, Mitra https://orcid.org/0009-0006-0686-4581
Fiscella, Michele https://orcid.org/0000-0003-3869-9948
Harrison, Travis https://orcid.org/0000-0003-0722-6101
Hofer, Magdalena https://orcid.org/0009-0003-7796-7770
Janetzki, Sylvia https://orcid.org/0009-0005-9758-2186
Jawa, Vibha https://orcid.org/0000-0001-7019-729X
Long, Brian https://orcid.org/0000-0003-1350-0293
Lu, Yanmei https://orcid.org/0000-0002-2772-5154
Mahnke, Yolanda D. https://orcid.org/0000-0002-2727-9887
Maia, Mauricio https://orcid.org/0000-0002-0856-3313
Majumdar, Ritankar https://orcid.org/0000-0001-6624-0187
Miller, Michelle https://orcid.org/0000-0002-2728-8820
Milton, Mark https://orcid.org/0009-0008-0972-0908
Nelson, Robert https://orcid.org/0009-0004-9144-1182
Partridge, Michael A. https://orcid.org/0000-0001-6699-8473
Shaik, Saleem https://orcid.org/0000-0002-9071-5784
Snoeck, Veerle https://orcid.org/0009-0009-3480-0894
Vettermann, Christian https://orcid.org/0000-0003-3794-6441
Wu, Bonnie https://orcid.org/0000-0003-3606-4420
Article History
Received: 22 July 2025
Accepted: 20 November 2025
First Online: 5 January 2026
Declarations
:
: The authors are employed by and receive compensation from companies that are involved in development of gene therapy modality therapeutics which are listed on the title page of the manuscript. The authors have no other relevant affiliations or financial involvements with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
: The views and conclusions presented in this paper are those of the authors and do not necessarily reflect the representative’s affiliation or company’s position on the subject.